WallStreetZenWallStreetZen

NASDAQ: COYA
Coya Therapeutics Inc Stock Ownership - Who owns Coya Therapeutics?

Insider buying vs selling

Have Coya Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ann LeeDirector2023-08-221,000$3.62
$3.62kBuy

1 of 1

COYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COYA insiders and whales buy or sell their stock.

COYA Shareholders

What type of owners hold Coya Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Greenlight Capital Inc8.76%1,274,026$10.96MInstitution
Aigh Capital Management LLC7.10%1,031,977$8.88MInstitution
Howard Berman6.53%949,338$8.16MInsider
Bertex LLC6.46%939,338$8.08MInsider
Wilbur L. Ross Jr.1.13%165,016$1.42MInsider
Cm Management LLC0.69%100,000$860.00kInstitution
Vanguard Group Inc0.67%97,152$835.51kInstitution
Worth Venture Partners LLC0.64%92,667$796.94kInstitution
Geode Capital Management LLC0.64%92,465$795.20kInstitution
Prelude Capital Management LLC0.25%35,770$307.62kInstitution

1 of 3

COYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COYA19.41%14.62%Net Buying
OMGA57.75%42.25%Net Selling
MCRB59.28%30.14%Net SellingNet Selling
SEER54.70%45.30%Net BuyingNet Selling
VXRT9.16%69.71%Net SellingNet Selling

Coya Therapeutics Stock Ownership FAQ

Who owns Coya Therapeutics?

Coya Therapeutics (NASDAQ: COYA) is owned by 19.41% institutional shareholders, 14.62% Coya Therapeutics insiders, and 65.97% retail investors. Howard Berman is the largest individual Coya Therapeutics shareholder, owning 949,338.00 shares representing 6.53% of the company. Howard Berman's Coya Therapeutics shares are currently valued at $8.16M.

If you're new to stock investing, here's how to buy Coya Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.